Publications by authors named "Matthew Sims"

Claim this Profile
O
Opportunities for RNA sequencing in physiology: from big data to understanding homeostasis and heterogeneity.
Jeremy W Prokop, Stephanie M Bilinovich, Ember Tokarski, Sangeetha Vishweswaraiah, Sophie VanderWeele, Matthew Sims

Function (Oxf)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparability of Gastrointestinal Microbiome and Bile Acid Profiles in Patients With First or Multiply Recurrent Clostridioides difficile Infection.
Jessica A Bryant, Timothy J Straub, Darrell S Pardi, Kevin D Litcofsky, Colleen R Kelly, Matthew Sims

J Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective global study of the prevalence of O-serotypes of invasive disease in patients admitted to tertiary care hospitals.
Jeroen Geurtsen, Joachim Doua, Luis Martinez-Martinez, Patricia Ibarra de Palacios, Jeff Powis, Matthew Sims

Epidemiol Infect· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New diagnostic methods for and the first report of its identification in clinical isolates in North America.
Pelumi M Oladipo, Robert J Tibbetts, Audun Sivertsen, Justin M Barger, Torbjørn S Bruvold, Matthew Sims

Front Microbiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial.
Nicholas A Turner, Toshimitsu Hamasaki, Sarah B Doernberg, Thomas P Lodise, Heather A King, Matthew Sims

JAMA· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multivariate protein landscape of host response in hospitalised patients with suspected infection in the emergency department.
Pratik Sinha, Alexandra B Spicer, Sivasubramanium Bhavani, Carlos López-Espina, Gregory L Watson, Matthew D Sims

Nat Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative Pathogens.
Mariya Huralska, Jason M Pogue, Michael Rybak, Jacinda C Abdul-Mutakabbir, Kyle Stamper, Matthew Sims

Clin Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From castaways to discoveries: unveiling treasures in skin RNAseq using a novel multidimensional data processing workflow including infection-host dynamics.
Disha Bhargava, Alec Labadie, Rebecca L Hanson-Rios-Stutz, Austin Goodyke, Ella M Moses, Matthew D Sims

Physiol Genomics· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the prospects of basal cognition research becoming fully evolutionary: promising avenues and cautionary notes.
Alejandro Fábregas-Tejeda, Matthew Sims

Hist Philos Life Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The common VTE-protective G haplotype of F5 increases factor V-short, TFPI function, and risk of bleeding.
Matthew C Sims, Magdalena Gierula, Jonathan C Stephens, Alex Tokolyi, Luca Stefanucci

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct immune profiles and clinical outcomes in sepsis subphenotypes based on temperature trajectories.
Sivasubramanium V Bhavani, Alexandra Spicer, Pratik Sinha, Albahi Malik, Carlos Lopez-Espina, Matthew Sims

Intensive Care Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
Colleen S Kraft, Matthew Sims, Michael Silverman, Thomas J Louie, Paul Feuerstadt

Infect Dis Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
Colleen S Kraft, Matthew Sims, Michael Silverman, Thomas J Louie, Paul Feuerstadt

Infect Dis Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Genotyping Highlights the Challenges in Spike Protein Drift Independent of Other Essential Proteins.
Jeremy W Prokop, Sheryl Alberta, Martin Witteveen-Lane, Samantha Pell, Hosam A Farag, Matthew D Sims

Microorganisms· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bile salt hydrolase acyltransferase activity expands bile acid diversity.
Douglas V Guzior, Maxwell Okros, Madison Shivel, Bruin Armwald, Christopher Bridges, Matthew D Sims

Nature· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Protein Biomarkers From Hospitalized COVID-19 Patients Reveals Severity-Specific Signatures and Two Distinct Latent Profiles With Differential Responses to Corticosteroids.
Philip A Verhoef, Alexandra B Spicer, Carlos Lopez-Espina, Akhil Bhargava, Lee Schmalz, Matthew D Sims

Crit Care Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of pathogenic and likely pathogenic variants for inherited hemostasis disorders in 140 214 UK Biobank participants.
Luca Stefanucci, Janine Collins, Matthew C Sims, Inigo Barrio-Hernandez, Luanluan Sun

Blood· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based Therapeutic.
Charles S Berenson, Bret Lashner, Louis Y Korman, Elizabeth Hohmann, Abhishek Deshpande, Matthew Sims

Clin Infect Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza vaccine effectiveness against hospitalized SARS-CoV-2 infection.
Yung-Chun Lee, Lufeiya Liu, Liyang Yuan, Malcolm Risk, Kevin Heinrich, Matthew Sims

medRxiv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Falsely decreased vancomycin caused by rheumatoid factor: A case report.
Mai Elzieny, Jordan A Fisher, Matthew D Sims, Carl B Lauter, Robin A Carey-Ballough

Clin Chim Acta· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Propensity-Matched Cohort Assessing Impact of a Neutralizing Monoclonal Antibody in Mild-to-Moderate Coronavirus Disease 2019.
Malak Abbas, Nada Farhat, Zainab Hammoud, Curtis Dickey, Ali Shuayto, Matthew Sims

J Intensive Care Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Metabolomic Biomarkers with Sleeve Gastrectomy Weight Loss Outcomes.
Wendy M Miller, Kathryn M Ziegler, Ali Yilmaz, Nazia Saiyed, Ilyas Ustun, Matthew D Sims

Metabolites· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing.
Matthew D Sims, Robert H Podolsky, Karen L Childers, Barbara Higgins, Jillian Trueman

J Immunol Methods· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial.
Matthew D Sims, Sahil Khanna, Paul Feuerstadt, Thomas J Louie, Colleen R Kelly

JAMA Netw Open· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms.
Keith S Kaye, Dror Marchaim, Visanu Thamlikitkul, Yehuda Carmeli, Cheng-Hsun Chiu, Matthew Sims

NEJM Evid· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis